跳至主要内容
临床试验/NCT05736094
NCT05736094已完成不适用

Dual-frequency Ultrasound for Detection of Prostate Cancer

Oslo University Hospital2 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2023年2月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
11
试验地点
2
主要终点
Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.

研究概览

简要总结

Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.

详细描述

Prospectively recruited patients before prostatectomy and/or definitive radiotherapy will be included in the study. Dual-frequency ultrasound imaging will be compared to standard transrectal ultrasound and MRI. Imaging of primary tumor with dual-frequency ultrasound technology including the use of microbubble contrast-media.

A prostate biopsy and blood sample will be taken from each patient, for histopathology and explorative biomarkers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age 18 years onwards
  • Signed written informed consent to perform rectal and transperineal ultrasound

排除标准

  • 未提供

结局指标

主要结局

Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.

时间窗: 1 day

Sensitivity and specificity outcome measures

次要结局

未报告次要终点

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wolfgang Lilleby

Principal Investigator

Oslo University Hospital

研究点 (2)

Loading locations...

相似试验